Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 578)
Posted On: 10/21/2020 12:10:22 AM
Post# of 153834
Posted By: Borel Fields
Increasing mortality to 42 days is a cheap way to increase "N." Information lies in events (deaths), not enrollees.

Can we ask NP the number dead at 28 days vs. at 42 days in the interim analysis? Is it the difference between the 45 number he mentioned once and the 50+ cited later? That's the effective increase in study enrollment.

I obviously assume they will assess 42 day death on all trial participants - not just new ones.













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site